NMS-859 is primarily investigated for its potential therapeutic applications in the field of oncology. It is being studied as a selective inhibitor targeting specific pathways involved in cancer cell proliferation and survival. Researchers are exploring its efficacy in preclinical models to determine its ability to inhibit tumor growth, particularly in cancers that are resistant to conventional therapies. Additionally, NMS-859 is being evaluated for its potential to enhance the effectiveness of existing cancer treatments when used in combination therapies. Its role in modulating key cellular processes makes it a promising candidate for further development in cancer treatment strategies.